Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adrian Schmidt

Showing results (41-50 of 47) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 47 results.
Bone Marrow Transplantation|November 4, 2018
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry studyGuido Ghilardi, Thomas Pabst, Barbara Jeker, et al.
Cancers|July 2, 2021
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision MedicineIoannis Chanias, Kristina Stojkov, Gregor Th Stehle, et al.
Hemasphere|June 24, 2022
Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q)Axel Rüfer, Hubert Angermann, Rudolf Benz, et al.
Swiss Medical Weekly|March 2, 2018
Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016Jakob R Passweg, Helen Baldomero, Marc Ansari, et al.
Swiss Medical Weekly|August 14, 2025
Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis NetworkMax J Rieger, Andreas J Flammer, Sabine Gerull, et al.
Swiss Medical Weekly|October 25, 2021
Management of transthyretin amyloidosisAdalgisa Condoluci, Marie Théaudin, Rahel Schwotzer, et al.
Swiss Medical Weekly|December 5, 2020
Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosisRahel Schwotzer, Andreas J Flammer, Sabine Gerull, et al.
Pageof 5

Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Bone Marrow Transplantation|November 4, 2018
Melphalan dose in myeloma patients ≥65 years of age undergoing high-dose therapy and autologous stem cell transplantation: a multicentric observational registry studyGuido Ghilardi, Thomas Pabst, Barbara Jeker, et al.
Cancers|July 2, 2021
Myelodysplastic Syndromes in the Postgenomic Era and Future Perspectives for Precision MedicineIoannis Chanias, Kristina Stojkov, Gregor Th Stehle, et al.
Hemasphere|June 24, 2022
Real-world Data From the Swiss Lenalidomide in MDS del(5q) (SLIM)-Registry Identify New Chances and Challenges in Lenalidomide Treatment of Patients With MDS del(5q)Axel Rüfer, Hubert Angermann, Rudolf Benz, et al.
Swiss Medical Weekly|March 2, 2018
Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016Jakob R Passweg, Helen Baldomero, Marc Ansari, et al.
Swiss Medical Weekly|August 14, 2025
Updated recommendations for the treatment of light-chain amyloidosis from the Swiss Amyloidosis NetworkMax J Rieger, Andreas J Flammer, Sabine Gerull, et al.
Swiss Medical Weekly|October 25, 2021
Management of transthyretin amyloidosisAdalgisa Condoluci, Marie Théaudin, Rahel Schwotzer, et al.
Swiss Medical Weekly|December 5, 2020
Expert recommendation from the Swiss Amyloidosis Network (SAN) for systemic AL-amyloidosisRahel Schwotzer, Andreas J Flammer, Sabine Gerull, et al.
Pageof 5